In Vitro and In Silico Studies of Maculosin as a Melanogenesis and Tyrosinase Inhibitor
Molecules · 2025
DOI: 10.3390/molecules30040860 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2025. Verfasst von Yang Xu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry and Cosmetics, Jeju Inside Agency and Cosmetic Science Center, Jeju National University, Jeju 63243, Republic of Korea. Hauptthemen laut MEDLINE: Monophenol Monooxygenase, Melanins, Enzyme Inhibitors. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: "Regional Innovation Strategy (RIS)" through the National Research Foundation of Korea funded by the Ministry of Education, Ministry of Education.
Abstract (Originalsprache)
The investigation of melanogenesis and tyrosinase inhibitors is essential for developing safe and effective natural compounds to treat pigmentation disorders. This study aimed to evaluate the effects of maculosin, a cyclic dipeptide composed of tyrosine and proline, on melanin production and tyrosinase activity using the B16F10 melanoma cell model, while elucidating its mechanism of action through molecular docking and molecular dynamics (MD) simulations. Experimental results demonstrated that maculosin inhibited intracellular melanin content and tyrosinase activity in a concentration-dependent manner in B16F10 melanoma cells. Molecular docking analyses revealed that maculosin exhibited high binding affinities with mushroom tyrosinase (mTYR), tyrosinase-related protein 1 (TYRP1), and Bacillus megaterium tyrosinase (BmTYR) with binding energies of −7.7, −6.8, and −7.5 kcal/mol, respectively. Furthermore, MD simulations confirmed the structural stability and dynamic flexibility of maculosin–protein complexes, as indicated by RMSD, RMSF, Rg, SASA, hydrogen bond interactions, PCA, and DCCM analyses. Binding free energy calculations using the MM/PBSA method showed that maculosin exhibited binding energies of −28.76 kcal/mol with mTYR and −22.23 kcal/mol with TYRP1, outperforming standard co-crystal inhibitors such as tropolone (−12.47 kcal/mol) and kojic acid (−12.73 kcal/mol). Critical residues, including VAL-283 and HIS-263 in mTYR and HIS-381, GLY-389, and THR-391 in TYRP1, were identified as key contributors to maculosin binding, corroborating molecular docking findings and displaying strong correlations in DCCM analyses. Collectively, these results suggest that maculosin is a highly promising candidate for the treatment of pigmentation disorders, offering significant inhibitory effects on melanogenesis and tyrosinase activity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry and Cosmetics, Jeju Inside Agency and Cosmetic Science Center, Jeju National University, Jeju 63243, Republic of Korea.
- Department of Beauty and Cosmetology, Jeju National University, Jeju 63243, Republic of Korea.
ORCID-Profile: Yang Xu, Xuhui Liang, Hyeon-Mi Kim, Chang-Gu Hyun
Förderung
- "Regional Innovation Strategy (RIS)" through the National Research Foundation of Korea funded by the Ministry of Education
- Ministry of Education
Zitieren
APA
Xu, Y., Liang, X., Kim, H. M., & Hyun, C. G. (2025). In Vitro and In Silico Studies of Maculosin as a Melanogenesis and Tyrosinase Inhibitor. Molecules. https://doi.org/10.3390/molecules30040860
Vancouver
Xu Y, Liang X, Kim HM, Hyun CG. In Vitro and In Silico Studies of Maculosin as a Melanogenesis and Tyrosinase Inhibitor. Molecules. 2025. doi:10.3390/molecules30040860
BibTeX
@article{Xu2025,
author = {Xu, Yang and Liang, Xuhui and Kim, Hyeon-Mi and Hyun, Chang-Gu},
title = {In Vitro and In Silico Studies of Maculosin as a Melanogenesis and Tyrosinase Inhibitor},
journal = {Molecules},
year = {2025},
doi = {10.3390/molecules30040860}
}
EUVIMED